Home
About
About MGB
Team
Board of Directors
Scientific Advisory Board
Investors
Strategy
Our Strategy
Market Opportunity
Partnering
Platform
The MGB Advantage
Minor Groove Binders
Intellectual Property & Collaborators
Pipeline
Antibacterials
Oral Programme
Intravenous Programme
Topical Programme
Programmes Overview
News
News
Events
Publications
Useful Links
Contact
Contact Us
Careers
MENU
Publications
ECCMID 2013
Bio Europe 2013
Gaining Traction Against Antimicrobial Resistance 2014
EPC Article 2014
UoS Minor Groove Binders e-book 2015
Superbugs & Superdrugs 2015
UoS Adjacent Government Note on MGBs 2015
BioTrinity Part 1 2015
BioTrinity Part 2 2015
BioTrinity Part 3 2015
ICAAC 2015 Poster 1
ICAAC 2015 Poster 2
2016-ASM-Microbe-Poster
ICAAC 2013
ICAAC 2013
News
MGB Biopharma – FDA and Health Canada Clear IND/CTA Applications for MGB-BP-3
READ MORE
Scottish Biopharmaceutical Company MGB Biopharma Receives £2.78
READ MORE
MGB Biopharma – FDA and Health Canada Clear IND/CTA Applications for MGB-BP-3
READ MORE
Scottish Biopharmaceutical Company MGB Biopharma Receives £2.78
READ MORE
MGB Biopharma – FDA and Health Canada Clear IND/CTA Applications for MGB-BP-3
READ MORE
Join our mailing list
Δ
Menu
Home
About
About MGB
Team
Board of Directors
Scientific Advisory Board
Investors
Back
Strategy
Our Strategy
Market Opportunity
Partnering
Back
Platform
The MGB Advantage
Minor Groove Binders
Intellectual Property & Collaborators
Back
Pipeline
Antibacterials
Oral Programme
Intravenous Programme
Topical Programme
Programmes Overview
Back
News
News
Events
Publications
Useful Links
Back
Contact
Contact Us
Careers
Back
× Close Panel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Ok
No
Cookie policy